PAPER
Solvent-free Synthesis of Unsymmetrical Benzoyldisulfides
Compounds 5 (R1 = Cl)
1039
1H NMR (300 MHz, CDCl3): = 7.98 (d, 2H, J = 7.5 Hz, Bz-
2,6),7.60 (t, 1H, J = 7.5 Hz, Bz-4), 7.51 (d, 2H, J = 8.0 Hz, tolyl-
2,6), 7.47 (t, 2H, J = 7.5 Hz, Bz-3,5), 7.11 (d, 2H, J = 8.0 Hz, tolyl-
3,5), 2.31 (s, 3H, CH3).
13C NMR (75 MHz, CDCl3): = 189.38 (C=O), 138.86 (tolyl-4),
135.56 (Bz-1), 134.10 (Bz-4), 132.39 (tolyl-1), 131.48 (tolyl-3,5),
129.92 (tolyl-2,6), 128.84 (Bz-3,5), 127.8 4 (Bz-2,6), 21.17 (CH3).
Prepared by Method 1 with 2b. The oily products were subjected to
chromatography (method 2).
5a (R2 = Me)
Colorless oil.
IR (thin film): = 1686.00 (C=O) cm–1.
MS (EI): m/z (%)= 260 (3.55) [M]+, 246 (8.23), 123 (15.50), 105
1H NMR (300 MHz, CDCl3): = 7.92 (d, 2H, J = 9.0 Hz, Bz-2,6),
7.46 (d, 2H, J = 9.0 Hz, Bz-3,5), 2.48 (s, 3H, CH3).
(100) [PhCO]+, 77 (36.43).
Anal. Calcd for C14H12OS2: C, 64.58; H, 4.65. Found: C, 64.52; H,
4.77.
13C NMR (75 MHz, CDCl3): =189.14 (C=O), 140.58 (Bz-4),
134.04 (Bz-1), 129.25 (Bz-2,6), 129.02 (Bz-3,5), (22.60, CH3).
MS (EI): m/z (%) = 218 (0.45) [M]+, 139 (100) [ClPhCO]+, 111
(28.77).
4g (R2 = p- fluorophenyl)
Colorless oil.
IR (thin film): = 1691.79 (C=O) cm–1.
1H NMR (300 MHz, CDCl3): = 7.98 (d, 2H, J = 7.5 Hz, Bz-2,6),
7.63 (t, 1H, J = 7.5, Bz-4), 7.61 (d, 2H, J = 8.5 Hz, Ph-2,6), 7.48 (t,
2H, J = 7.5 Hz, Bz-3,5),7.00 (dd, 2H, J = 8.5 Hz, Ph-3,5, JoH-F = 9.0
Hz).
Anal. Calcd for C8H7ClOS2: C, 43.93; H, 3.23. Found: C, 44.03; H,
3.39.
5b (R2 = benzyl)
Colorless.
Mp 65.0–66.0°C.
IR (KBr): = 1695.64 (C=O) cm–1.
13C NMR (75 MHz, CDCl3): = 189.11 (C=O), 164.08 (JC-F
=
247.5 Hz), 135.36 (Bz-1), 134.28 (Bz-4), 133.90 (JmC-F = 8.3 Hz),
131.14 (JPC-F = 2.8 Hz), 128.96 (Bz-3,5), 127.86 (Bz-2,6), 116.31
(JoC-F = 21.9 Hz).
1H NMR (300 MHz, CDCl3): = 7.88 (d, 2H, J = 9.0 Hz, Bz-2,6),
7.45 (d, 2H, J = 9.0 Hz, Bz-3,5), 7.33–7.27 (m, 5H, Bn), 4.00 (s, 2H,
Bn-CH2).
13C NMR (75 MHz, CDCl3): = 189.01 (C=O), 140.58 (Bn-1),
136.00 (Bz-4), 134.07 (Bz-1), 129.52 (Bz-2,6), 129.23 (Bz-3,5),
129.05 (Bn-3,5), 128.60 (Bn-2,6), 127.83 (Bn-4), 42.73 (Bn CH2).
MS (EI): m/z (%) = 264 (1.98) [M]+, 159 (3.91), 127 (25.28), 105
(100) [PhCO]+, 77 (56.68).
Anal. Calcd for C13H9FOS2: C, 59.07; H, 3.43. Found: C, 58.85; H,
3.52.
MS (EI): m/z (%) = 294 (0.69) [M]+, 139 (100) [ClPhCO]+, 111
4h (R2 = p-bromophenyl)
(20.52), 91 (25.94).
Colorless.
Anal. Calcd for C14H11ClOS2: C, 57.04; H, 3.76. Found: C, 56.85;
H, 3.85.
Mp 45.5–47.0°C.
IR (KBr): = 1693.72 cm–1.
5c (R2 = cyclohexyl)
Colorless oil.
IR (thin film): = 1689.86 (C=O) cm–1.
1H NMR (300 MHz, CDCl3): = 7.95 (d, 2H, J = 8.5 Hz, Bz-2,6),
7.46 (d, 2H, J = 8.5 Hz, Bz-3,5), 2.87 (nonet, 1H, J = 3.6 Hz, Cy-1),
2.05 (2H), 1.80 (2H), 1.61 (1H), 1.46–1.29 (m, 5H, Cy).
13C NMR (75 MHz, CDCl3): = 189.84 (C=O), 140.45 (Bz-
4),134.18 (Bz-1),129.17 (Bz-2,6), 129.06 (Bz-3,5), 49.75 (Cy-1),
32.64 (Cy-2,6), 25.99 (Cy-3,5), 25.48 (Cy-4).
1H NMR (300 MHz, CDCl3): = 7.79 (d, 2H, J = 8.0 Hz, Bz-2,6),
7.63 (t, 1H, J = 8.0 Hz, Bz-4), 7.49 (t, 2H, J = 8.0 Hz, Bz-3,5), 7.45
(d, 2H, J = 8.5, Ph-3,5), 7.42 (d, 2H, J = 8.5 Hz, Ph-2,6).
13C NMR (75 MHz, CDCl3): = 188.70 (C=O), 135.24 (Bz-1),
135.01 (Ph-1), 134.39 (Bz-4), 132.22 (Ph-3,5), 132.06 (Ph-2,6),
129.01 (Bz-3,5), 127.92 (Bz-2,6), 122.59 (Ph-4).
MS (EI): m/z (%) = 324 (0.66) [M]+, 219 (0.37), 187 (7.21), 105
(100) [PhCO]+, 77 (29.02).
Anal. Calcd for C13H9BrOS2: C, 48.01; H, 2.79. Found: C, 48.15; H,
2.87.
MS (EI): m/z (%) = 286 (1.58) [M]+, 139 (100) [ClPhCO]+, 111
(14.43), 83 (2.84).
4i (R2 = 2-naphthyl)
Colorless.
Anal. Calcd for C13H15ClOS2: C, 54.44; H, 5.27. Found: C, 54.50;
H, 5.37.
Mp 69.0–70.0°C (Lit.4a 69°C).
IR (KBr): = 1695.64 (C=O) cm–1.
5d (R2 = phenyl)
Colorless.
1H NMR (300 MHz, CDCl3): = 8.09 (s, 1H, naph-1), 8.02 (d, 2H,
J = 7.5 Hz, Bz-2,6), 7.78 (d, 3H, J = 7.5 Hz, naph-4,5,8), 7.62(t, 2H,
J = 7.5 Hz, naph-6,7), 7.49 (t, 3H, J = 7.5 Hz, Bz-3,4,5), 7.47 (d, 1H,
J = 7.5 Hz, naph-3).
13C NMR (75 MHz, CDCl3): = 189.12 (C=O), 135.47 (Bz-1),
135.46 (naph-9), 134.24 (Bz-4), 133.34 (naph-10), 132.91 (naph-2),
129.95 (naph-1), 129.05 (Bz-3,5), 128.96 (naph-4), 127.91 (naph-
5,8), 127.74 (Bz-2,6), 126.76 (naph-6,7), 126.72 (naph-3).
Mp 79.0–80.0°C.
IR (KBr): = 1686.00 (C=O) cm–1.
1H NMR (300 MHz, CDCl3): = 7.94 (d, 2H, J = 8.4 Hz, Bz-2,6),
7.57 (dd, 2H, J = 2.0, 7.5 Hz, Ph-2,6), 7.46 (d, 2H, J = 8.4 Hz, Bz-
3,5), 7.31–7.28 (m, 3H, Ph-3,4,5).
13C NMR (75 MHz, CDCl3): = 188.19 (C=O), 140.77 (Bz-4),
135.53 (Ph-1), 133.75 (Bz-1), 130.69 (Bz-2,6), 129.30 (Ph-2,6),
129.20 (Bz-3,5), 129.20 (Ph-3,5), 128.47 (Ph-4).
MS (EI): m/z (%) = 296 (7.69) [M]+, 219 (0.37), 187 (7.21), 105
MS (EI): m/z (%) = 280 (2.08) [M]+, 248, 139 (100) [ClPhCO]+, 111
(19.98), 109 (11.75).
(100) [PhCO]+, 77 (29.02).
Anal. Calcd for C17H12OS2: C, 68.89; H, 4.08. Found: C, 68.56; H,
4.20.
Anal. Calcd for C13H9ClOS2: C, 55.61; H, 3.23. Found: C, 55.27; H,
3.31.
Synthesis 2001, No. 7, 1035–1042 ISSN 0039-7881 © Thieme Stuttgart · New York